コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 resistance (AMR) is a significant threat to global health.
2 egies and usher in a new approach to improve global health.
3 research and have important implications for global health.
4 flavivirus that represents a major threat to global health.
5 ms of TB a major goal for the improvement of global health.
6 Antibiotic resistance is a major threat to global health.
7 years represents an important emergence for global health.
8 contributions of all participants to enhance global health.
9 asles immunity is a fundamental challenge to global health.
10 tobacter baumannii poses a growing threat to global health.
11 -2) pandemic creates a significant threat to global health.
12 bacteria, are one of the biggest threats to global health.
13 inable Development Goal target for improving global health.
14 sential to human well-being but neglected in global health.
15 tic resistance poses an increasing threat to global health.
16 navirus 2 (SARS-CoV-2), is a major threat to global health(1) and the medical countermeasures availab
17 stance data for HIV/AIDS were from Financing Global Health 2018, and HIV/AIDS prevalence, incidence,
22 to address challenges unique to the field of global health and accelerate achievement of the health-r
23 g and may not require cold chain storage for global health and developed world long-acting drug deliv
27 thiness of AI for medical decision making in global health and low-resource settings is hampered by i
30 ients) and this Summit's particular focus on global health and the Sustainable Development Goals offe
31 t represent an established ongoing threat to global health and those that have recently emerged in ne
33 study, we searched PubMed, MEDLINE, Embase, Global Health, and China National Knowledge Infrastructu
34 We searched MEDLINE, Embase, Web of Science, Global Health, and CINAHL for studies reporting HIV inci
39 enza viruses still pose a serious concern to global health, and neutralizing antibodies constitute a
40 -analysis, we searched Embase, MEDLINE, Ovid Global Health, and PsychINFO databases for primary resea
42 -analysis, we searched MEDLINE, Embase, Ovid Global Health, and Web of Science databases from incepti
43 thod may not be robust enough to function in global health applications, point-of-care assays, or wea
44 utside militaries-for military engagement in global health are often lacking, as are structured oppor
45 and represents a clear and present danger to global health as new tools for vaccination, treatment, a
46 itoring studies of air pollution relevant to global health as well as occupational smoke exposures in
47 onaviruses (CoVs) are substantial threats to global health, as exemplified by the emergence of two se
48 new political commitment are needed if these global health aspirations and the wider Sustainable Deve
49 ery 6 months for 3 years postoperatively and global health assessed with EORTC-QLQC30 and esophageal
50 k of therapeutic agents for yellow fever put global health at risk, should this virus emerge from sub
51 terial infections remain a leading threat to global health because of the misuse of antibiotics and t
54 an metapneumovirus, represent a considerable global health burden, as recognised by WHO's Battle agai
62 ction of biomarkers would drastically impact global health by enabling decentralized disease diagnosi
63 his review can accelerate efforts to improve global health by leading to more strategic investment in
64 -analysis of five databases (PubMed, Embase, Global Health [CABI.org], Web of Science, and Global Ind
70 mortality and morbidity continue to be major global health challenges strongly associated with premat
71 ted the contribution of modelling to address global health challenges, exemplified by models for the
74 ormous effect on the research and public and global health communities well beyond the field of HIV/A
75 The Sustainable Development Goals offer the global health community a strategic opportunity to promo
78 rements, and shifting funding landscape, the global health community must accelerate the development
79 s might not be unique to these settings, the global health community will need to work quickly to est
80 us (ZIKV), a mosquito-borne flavivirus, is a global health concern because of its association with se
82 e to severe diarrhea caused by Shigella is a global health concern due to its substantial contributio
84 zation and industrialization causes a severe global health concern to both ecosystem and humanity.
85 in HCMV infection.IMPORTANCE HCMV is a major global health concern, and antiviral chemotherapy remain
86 irus (HBV) infection continues to be a major global health concern, and patients who fail to mount an
88 Chronic hepatitis B (CHB) is a significant global health concern, and the most prevalent blood-born
89 MPORTANCE Hepatitis B virus (HBV) is a major global health concern, chronically infecting millions of
97 would, however, increase the risk of further global health crises because the emergence of novel infe
110 d disaggregated disease burden data from the Global Health Data Exchange to produce country-level est
112 il 30, 2019, in PubMed, MEDLINE, Embase, the Global Health database, CINAHL, the Global Health Librar
113 ne Library, Web of Science, Popline, Cinahl, Global Health database, Emerald, Google Scholar, Science
115 ch of the AI-driven intervention research in global health does not describe ethical, regulatory, or
116 nsibilities, and approaches of militaries in global health, drawing on examples and case studies acro
119 of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs
121 obacteriaceae (CRE) infections has created a global health emergency, underlining the critical need t
131 to Nursing and Allied Health Literature, and Global Health) from inception to Dec 31, 2018, to identi
134 Gender equality in science, medicine, and global health has the potential to lead to substantial h
136 s have concerning implications for potential global health impacts, particularly for the pediatric po
142 that have emerged to finance these and other global health initiatives, we propose a multi-sectoral a
144 calling on leaders in national governments, global health institutions, civil society organisations,
145 equality for women in science, medicine, and global health is one of mixed gains and persistent chall
146 Enteropathogenic bacterial infections are a global health issue associated with high mortality, part
147 virus (ZIKV) infections have reemerged as a global health issue due to serious clinical complication
149 accination is an alternative to control this global health issue, however new low-cost vaccines are n
150 tner violence (IPV) against women is a major global health issue, particularly in low- and middle-inc
153 ase, the Global Health database, CINAHL, the Global Health Library, the Allied and Complementary Medi
154 erculosis (Mtb) remains a major challenge to global health, made worse by the spread of multi-drug re
155 hy gender equality in science, medicine, and global health matters for health and health-related outc
156 We searched 3 electronic databases including Global Health, Medline, and EMBASE for studies reporting
157 a meta-analysis by searching CINAHL, Embase, Global Health, Medline, and PsycINFO, for studies publis
158 We searched the Cochrane Library, Embase, Global Health, Medline, PsycINFO, Scopus, Web of Science
160 acteria is an increasingly serious threat to global health, necessitating the development of innovati
161 is drug discovery is critical to address the global health need and burgeoning multidrug resistance.
163 physical functioning (17 [39%] studies) and global health or quality of life (15 [34%] studies).
165 bMed, Embase (Ovid), CINAHL (Ebscohost), and Global Health (Ovid) databases for HIV-1 subtyping studi
166 bMed, EMBASE (Ovid), CINAHL (Ebscohost), and Global Health (Ovid) for HIV-1 subtyping studies publish
167 bMed, EMBASE (Ovid), CINAHL (Ebscohost), and Global Health (Ovid) for HIV-1 subtyping studies publish
170 l determinants, and their ongoing neglect in global health policy, we aim to highlight the urgent nee
171 rom the perspective of two key approaches to global health policy-global health security and universa
173 atory heart disease, was recently declared a global health priority by the World Health Organization.
175 contacts of patients with tuberculosis is a global health priority, but the effects of active versus
186 to available antibiotics represents a major global health problem and highlights the need for novel
189 curs with asthma and conjunctivitis and is a global health problem causing major burden and disabilit
196 tructive pulmonary disease (COPD) is a major global health problem that is poorly treated by current
198 Hepatitis B virus (HBV) remains a major global health problem with 257 million chronically infec
200 Hepatic fibrosis and cirrhosis are a growing global health problem with increasing mortality rates.
204 itis B virus (HBV) infection remains a major global health problem, exacerbated by poor linkage to ca
205 Undernutrition in children is a pressing global health problem, manifested in part by impaired li
206 Traumatic brain injury (TBI) is a serious global health problem, many individuals live with TBI-re
207 uate access to safe drinking water remains a global health problem, particularly in rural areas.
208 d-transmitted viruses represent a widespread global health problem, with limited treatment options cu
226 itaries have many capabilities applicable to global health, ranging from research, surveillance, and
227 e antibiotic resistance is a major threat to global health, recent observations that the traditional
228 sensing technique can find numerous uses in global health related applications in resource-limited e
229 ial College London Wellcome Trust Centre for Global Health Research, and Richard and Susan Kiphart Fa
230 im of infectious disease epidemiologists and global health researchers is to evaluate disease prevent
231 entions fit into four categories relevant to global health researchers: (1) diagnosis, (2) patient mo
232 nostics have played an essential role in the global health response to the novel coronavirus pandemic
233 ds gender equality in science, medicine, and global health, review the evidence for why gender equali
235 Rooted in learnings from the exemplars in Global Health's Stunting Reduction Exemplars project, we
237 and financial architecture of two successful global health scale-up efforts (the fight against HIV/AI
238 ew was performed using Ovid Medline, Embase, Global health, Scopus, and Web of Science for articles p
240 We observed no significant difference in global health score at 9 months (cross-sectional analysi
241 study, the co-primary endpoints were QLQ-C30 global health score at 9 months (cross-sectional analysi
242 (cross-sectional analysis) and mean QLQ-C30 global health score from randomisation to 9 months (long
243 Using longitudinal analysis, we found lower global health scores for those receiving weekly paclitax
245 During the peak period of migration, The Global Health Sector Strategy on Viral Hepatitis was ado
246 alth coverage, and integrated investments in global health security and universal health coverage) in
247 f two key approaches to global health policy-global health security and universal health coverage-imp
249 th systems (ie, with stronger investments in global health security, stronger investments in universa
253 Improvements from baseline in EORTC QLQ-C30 global health status and EQ-5D-5L visual analogue scale
256 ysical functioning (-1.9, -3.91 to 0.15), or global health status or quality of life (0.8, -1.55 to 3
257 [-1.10 to 1.28] vs 2.0 [0.22 to 3.73]), and global health status or quality of life (2.6 [1.21 to 3.
258 We assessed PRO symptoms, functioning, and global health status or quality of life in the intention
260 r Quality of Life Questionnaire Core 30-item global health status scores improved from baseline in bo
261 for Research and Treatment of Cancer QLQ-C30 Global health status scores were higher (better) in the
262 week 21 (following chemotherapy) in QLQ-C30 global health status/quality of life (GHS/QOL) score, an
264 history, and physiology currently influences global health surveillance and research in disease ecolo
265 With the current rapid spread of COVID-19, global health systems are increasingly overburdened by t
267 ns to recommit to the roll out of markets in global health, this involving the further scaling back o
268 ng epitope.IMPORTANCE Zika virus (ZIKV) is a global health threat causing severe disease in humans, i
273 phenotypes.IMPORTANCE CHIKV is a reemerging global health threat that elicits debilitating arthritis
274 Chikungunya virus (CHIKV) is a reemerging global health threat that produces debilitating arthriti
275 -borne flavivirus that emerged recently as a global health threat, causing a pandemic in the Americas
277 ction.IMPORTANCE Alphavirus infections are a global health threat, contributing to outbreaks of disea
280 t bacterial antibiotic resistance, a growing global health threat, it is imperative to understand its
289 istance poses one of the greatest threats to global health today; conventional drug therapies are bec
292 elopment Civil Society Challenge Fund, Joint Global Health Trials consortium, Bill & Melinda Gates Fo
293 artment for International Development, Joint Global Health Trials consortium, Bill & Melinda Gates Fo
294 ch, and the Wellcome Trust through the Joint Global Health Trials Scheme (MR/K007424/1) and the Bill
297 Bill & Melinda Gates Foundation, the Joint Global Health Trials Scheme of the Medical Research Coun